Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.952 |
High Similarity |
NPD4625 |
Phase 3 |
0.935 |
High Similarity |
NPD4749 |
Approved |
0.8992 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8992 |
High Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8984 |
High Similarity |
NPD4908 |
Phase 1 |
0.873 |
High Similarity |
NPD1610 |
Phase 2 |
0.8667 |
High Similarity |
NPD6100 |
Approved |
0.8667 |
High Similarity |
NPD6099 |
Approved |
0.8397 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8271 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8268 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8195 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8195 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8175 |
Intermediate Similarity |
NPD6671 |
Approved |
0.813 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.8106 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.8029 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8029 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7969 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7874 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7832 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7761 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7714 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7714 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7681 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.766 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7655 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7655 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7643 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7582 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7556 |
Intermediate Similarity |
NPD1608 |
Approved |
0.754 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7519 |
Intermediate Similarity |
NPD7635 |
Approved |
0.75 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7466 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7464 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7464 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7463 |
Intermediate Similarity |
NPD4626 |
Approved |
0.745 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7426 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7426 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7419 |
Intermediate Similarity |
NPD940 |
Approved |
0.7419 |
Intermediate Similarity |
NPD846 |
Approved |
0.7413 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7403 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7397 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7394 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7377 |
Intermediate Similarity |
NPD288 |
Approved |
0.7376 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7376 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7339 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7333 |
Intermediate Similarity |
NPD17 |
Approved |
0.7329 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7323 |
Intermediate Similarity |
NPD968 |
Approved |
0.7319 |
Intermediate Similarity |
NPD3225 |
Approved |
0.731 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7295 |
Intermediate Similarity |
NPD844 |
Approved |
0.7292 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7286 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7267 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD3749 |
Approved |
0.726 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7258 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7252 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7239 |
Intermediate Similarity |
NPD7644 |
Approved |
0.7226 |
Intermediate Similarity |
NPD37 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7218 |
Intermediate Similarity |
NPD709 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD7030 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7197 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7194 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7192 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7162 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7132 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7132 |
Intermediate Similarity |
NPD290 |
Approved |
0.7125 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD6815 |
Approved |
0.7083 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.708 |
Intermediate Similarity |
NPD4059 |
Approved |
0.7077 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD5929 |
Approved |
0.707 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7067 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1512 |
Approved |
0.705 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD1712 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7023 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7023 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7023 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7021 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7021 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7016 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7016 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7014 |
Intermediate Similarity |
NPD7294 |
Phase 1 |
0.7007 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7007 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7007 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7007 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD2533 |
Approved |
0.6993 |
Remote Similarity |
NPD2532 |
Approved |
0.6993 |
Remote Similarity |
NPD2534 |
Approved |
0.6992 |
Remote Similarity |
NPD845 |
Approved |
0.6978 |
Remote Similarity |
NPD1201 |
Approved |
0.6978 |
Remote Similarity |
NPD3092 |
Approved |
0.6978 |
Remote Similarity |
NPD1281 |
Approved |
0.6975 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6974 |
Remote Similarity |
NPD6667 |
Approved |
0.6974 |
Remote Similarity |
NPD6666 |
Approved |
0.6963 |
Remote Similarity |
NPD6387 |
Discontinued |
0.6963 |
Remote Similarity |
NPD7157 |
Approved |
0.6963 |
Remote Similarity |
NPD2557 |
Approved |
0.6962 |
Remote Similarity |
NPD7046 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6957 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD2668 |
Approved |
0.6957 |
Remote Similarity |
NPD2667 |
Approved |
0.6957 |
Remote Similarity |
NPD5846 |
Approved |
0.6957 |
Remote Similarity |
NPD3019 |
Approved |
0.6957
|
Remote Similarity |
NPD5494 |
Approved |